Strengthening Lebanon's COVID-19 Response Project In Collaboration With The World Bank

Strengthening Lebanon's COVID-19 Response Project in Collaboration with the World Bank

Due to the unmet need for vaccines and the financial limitation of the GOL to meet the increasing health care needs, the “Strengthening Lebanon’s COVID-19 Response Project” will finance further purchase and deployment of equitable COVID-19 vaccines and needed supplies and activities to support the GOL COVID-19 response.

Strengthening Lebanon’s COVID-19 Response Project has a budget of US$29M and duration of two years and comprises the following components:
•   Component 1 – Procurement of COVID-19 vaccines and deployment:
This component will support the purchase of COVID-19 vaccines and related deployment activities.

•   Component 2- COVID-19 prevention, detection and case management:
This component will support other COVID-19 prevention, detection and case management activities.

•   Component 3 – System Strengthening, Monitoring and Management: This component will finance the project management unit, which includes at least: (i) financial management officers (FM), (ii) procurement and due diligence team; (iii) environmental and social officers; (iv) monitoring and evaluation officers and vi) Coordination. In addition, the component will support activities aimed at strengthening the health system in critical areas such as information systems, public health surveillance capacity, supply management/logistics, and expansion of primary health care settings.

Strengthening Lebanon’s Covid-19 Response (P178587)- Labor Management Procedures (LMP)- September 2022
Environmental and Social Management Framework (ESMF)- May 2022
Environmental and Social Commitment- (ESCP)- May 2022
Stakeholder Engagement Plan (SEP)- May 2022

All

ATC	Name	B/G	Ingredients	Form	Price
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg	Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg	Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg	Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg	Tablet, film coated	4,482,387 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml	Drops solution	950,097 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml	Drops solution	950,097 L.L
J05AR18	GENVOYA	B	Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg	Tablet, film coated	77,789,650 L.L
D07CC02	GENTACORT-FC	G	Fluocinolone acetonide - 0.01%, Clotrimazole - 1%, Gentamicin (sulfate) - 0.1%	Cream	302,365 L.L
C05CA54	GINKOR FORT	B	Heptaminol HCl - 0.300g, Troxerutine - 0.300g, Ginkgo biloba extract - 0.014g	Capsule	681,328 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml	Injectable suspension	791,523 L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg	Tablet, sugar coated, slow release	819,744 L.L
A02BX13	GAVISCON	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 267mg/10ml, Calcium (carbonate) - 160mg/10ml	Liquid	295,645 L.L
A02BX13	GAVISCON INFANT	B	Sodium alginate - 225mg, Magnesium alginate - 87.5mg	Powder for suspension	710,893 L.L
A02BX13	GAVISCON ADVANCE ANISEED FLAVOR	B	Sodium alginate - 1000mg/10ml, Potassium hydrogen carbonate - 200mg/10ml	Suspension	514,692 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml	Injectable suspension	14,139,396 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 250mg, Sodium bicarbonate - 106.5mg, Calcium (carbonate) - 187.5mg	Tablet, chewable	456,906 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 213mg/10ml, Calcium (carbonate) - 325mg/10ml	Suspension	542,912 L.L
A02BX13	GAVISCON DOUBLE ACTION	B	Sodium alginate - 500mg, Sodium bicarbonate - 213mg, Calcium (carbonate) - 325mg	Suspension	517,379 L.L
A02BX13	GAVISCON PEPPERMINT LIQUID	B	Sodium alginate - 250mg/10ml, Sodium bicarbonate - 133.5mg/10ml, Calcium (carbonate) - 80mg/10ml	Suspension	393,746 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg	Tablet, film coated	768,678 L.L
G01AA51	GYNAMEND	G	Nystatin - 100,000IU, Neomycin (sulfate) - 35,000IU, Polymyxin B sulfate - 35,000IU	Capsule, soft	345,560 L.L
R02AA05	GOLASEPTINE-LIDOCAINE	G	Chlorhexidine HCl - 5mg, Lidocaine HCl - 1mg	Tablet, chewable	736,426 L.L
D02AX	GLYCERINE	G	Glycerol -	Liquid	163,821 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 2.5mg	Tablet, film coated	563,663 L.L
A10BD02	GLYSTOR PLUS	G	Metformin HCl - 500mg, Glibenclamide - 2.5mg	Tablet, film-scored	533,697 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 5mg	Tablet, film coated	775,971 L.L
A10BD02	GLYSTOR PLUS	G	Metformin HCl - 500mg, Glibenclamide - 5mg	Tablet, film-scored	691,119 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 1000mg, Glibenclamide - 5mg	Tablet, film coated	1,006,220 L.L